Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease

Pituitary

Volumn 16, Issue 4, 2013, Pages 536-544

  Van Der Pas, R ^a   De Bruin, C ^a   Pereira, A M ^b   Romijn, J A ^b   Netea Maier, R T ^c   Hermus, A R ^c   Zelissen, P M ^d   De Jong, F H ^a   Van Der Lely, A J ^a   De Herder, W W ^a   Webb, S M ^e   Lamberts, S W J ^a   Hofland, L J ^a   Feelders, R A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cortisol diurnal rhythm; Cushing's disease; Medical treatment; Quality of life

Indexed keywords

CABERGOLINE; HYDROCORTISONE; KETOCONAZOLE; PASIREOTIDE;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL EVALUATION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SALIVA LEVEL; SCORING SYSTEM; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

ADULT; AGED; CIRCADIAN RHYTHM; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; HYDROCORTISONE; KETOCONAZOLE; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; QUALITY OF LIFE; QUESTIONNAIRES; SOMATOSTATIN; YOUNG ADULT;

EID: 84888201797     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0452-2     Document Type: Article

References (38)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602
2. Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 15:361-373
3. De Martin M, ecori Giraldi PF, Cavagnini F (2006) Cushing's disease. Pituitary 9:279-287
4. Kelly WF (1996) Psychiatric aspects of Cushing's syndrome. QJM 89:543-551
5. Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing's disease. Psychother Psychosom 67:140-146
6. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M (1993) Course of depression in cushing's syndrome: response to treatment and comparison with graves' disease. Horm Res 39:202-206
7. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 90:3279-3286
8. Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing's syndrome. Lancet 357:783-791
9. Santos A, Resmini E, Martinez MA, Marti C, Ybarra J, Webb SM (2009) Quality of life in patients with pituitary tumors. Curr Opin Endocrinol Diabetes Obes 16:299-303
10. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447-453
11. Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SW, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol 158:623-630
12. Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81-87
13. Keil MF, Merke DP, Gandhi R, Wiggs EA, Obunse K, Stratakis CA (2009) Quality of life in children and adolescents 1-year after cure of cushing syndrome: a prospective study. Clin Endocrinol 71:326-333
14. Johnston DG, Alberti KG, Nattrass M, Barnes AJ, Bloom SR, Joplin GF (1980) Hormonal and metabolic rhythms in Cushing's syndrome. Metabolism 29:1046-1052
15. Friedman TC, Garcia-Borreguero D, Hardwick D, Akuete CN, Doppman JL, Dorn LD, Barker CN, Yanovski JA, Chrousos GP (1994) Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome. Neuroendocrinology 60:626-634
16. Veldman RG, Frolich M, Pincus SM, Veldhuis JD, Roelfsema F (2000) Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy. J Clin Endocrinol Metab 85:4039-4046
17. Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B (2005) Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin Endocrinol 63:549-559
18. Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med 336:172-177
19. de Bruin C, Pereira AM, Feelders RA, Romijn JA, Roelfsema F, Sprij-Mooij DM, van Aken MO, van der Lelij AJ, de Herder WW, Lamberts SW, Hofland LJ (2009) Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab 94:1118-1124
20. Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW (2010) Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease. N Engl J Med 362:1846-1848
21. Nieman LK (2002) Medical therapy of Cushing's disease. Pituitary 5:77-82
22. Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clin Endocrinol 61:458-465
23. de Bos Kuil MJ, Endert E, Fliers E, Prummel MF, Romijn JA, Wiersinga WM (1998) Establishment of reference values for endocrine tests. I: Cushing's syndrome. Neth J Med 53:153-163
24. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E (1980) A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34:281-286
25. Hinz A, Klaiberg A, Schumacher J, Brahler E (2003) The psychometric quality of the Nottingham health profile (nhp) in the general population. Psychother Psychosom Med Psychol 53:353-358
26. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the hospital anxiety and depression Scale (hads) in different groups of Dutch subjects. Psychol Med 27:363-370
27. Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (mfi) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315-325
28. Smets EM, Visser MR, Willems-Groot AF, Garssen B, Schuster-Uitterhoeve AL, de Haes JC (1998) Fatigue and radiotherapy: (b) experience in patients 9 months following treatment. Br J Cancer 78:907-912
29. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the sf-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160-164
30. VanderZee KI, Sanderman R, Heyink J (1996) A comparison of two multidimensional measures of health status: the Nottingham health profile and the rand 36-item health survey 1.0. Qual Life Res 5:165-174
31. Krieger DT, Allen W, Rizzo F, Krieger HP (1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32:266-284
32. Liu JH, Kazer RR, Rasmussen DD (1987) Characterization of the twenty-four hour secretion patterns of adrenocorticotropin and cortisol in normal women and patients with Cushing's disease. J Clin Endocrinol Metab 64:1027-1035
33. Pereira AM, Tiemensma J, Romijn JA (2010) Neuropsychiatric disorders in Cushing's syndrome. Neuroendocrinology 92(Suppl 1):65-70
34. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123
35. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol 64:314-318
36. van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol 69:775-784
37. Santos A, Resmini E, Martinez-Momblan MA, Crespo I, Valassi E, Roset M, Badia X, Webb S (2012) Psychometric performance of the cushingqol questionnaire in conditions of real clinical practice. Eur J Endocrinol 167:337-342
38. Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. J Clin Endocrinol Metab 95:E129-E141